Lithoz and bioceramic supplies producer Himed have opened a brand new Bioceramics Heart of Excellence (BCoE) at Himed’s New York headquarters.
The 2 firms have been working collectively since 2023 and have opened the BCoE to allow a holistic method to R&D with bioceramics for medical system producers. To this finish, the BCoE will combine numerous analytical companies to assist the speedy prototyping course of, with Lithoz’s Lithography-based Ceramic Manufacturing (LCM) 3D printing expertise being applied on-site.
Based on the companions, the Lithoz LCM 3D printing expertise will likely be key to extending Himed’s speedy prototyping capabilities, increasing its choices for medical system producers to incorporate 3D printed implants. The power will present design assist and optimisation companies, in addition to SEM imaging, materials evaluation and characterisation, biomaterial customisation, and bioceramic 3D printing with the Lithoz CeraFab S65 Medical printer.
By providing these companies, Lithoz and Himed consider the ability will likely be of specific profit to medtech startups and different companies seeking to optimise designs that use bioceramics.
“Earlier than investing in a medical 3D printer, firms can successfully lease time on one, together with the assist and supplies experience of Himed’s engineers and scientists supporting them from idea by optimisation.”
“This new Bioceramics Heart of Excellence will open up a brand new chapter in 3D printed medical functions for North America,” added Lithoz CEO Dr. Johannes Homa. “We’re excited to be the expertise associate enabling Himed’s bioceramic innovation. With the mixture of Himed’s expertise and Lithoz expertise, new functions will definitely be enabled that are at present unthinkable.”
